Javascript must be enabled to continue!
A human monoclonal anti‐D antibody which detects a nonconformation‐dependent epitope on the RhD protein by immunoblot
View through CrossRef
We describe the first human monoclonal anti‐D (LOR‐15C9) which reacts with a D‐specific motif exposed either on a native form on intact D‐positive red cells or on a denatured form of the RhD protein (33 kD), and detected by immunoblotting. LOR‐15C9 was able to precipitate RhD but not RhcE proteins produced by in vitro transcription‐translation assays. The reactivity of the antibody, using panels of red cells with various partial D phenotypes known to lack some D epitopes and corresponding in RHD gene variants, suggested that LOR‐15C9 reactivity depends on the portion of the RhD polypeptide encoded by the exon 7 (amino acids 314–358). These findings correlate well with the reactivity of LOR‐15C9 with erythrocytes of some nonhuman primates (Dgor‐positive gorillas), but not of chimpanzee and Old or New World monkeys.In membrane proteins from partial DVI red cells, LOR‐15C9 detected two proteins of molecular weight 33 and 21 kD; the presence of the latter was specific for category DVI and presumably represented the product of an alternatively spliced RHDVI transcript in these cells. This is consistent with the finding that LOR‐15C9 can precipitate a shortened D protein mutant resulting from in vitro transcription‐translation and lacking amino‐acids 163–313 encoded by exons 4–6. In addition, a 21 kD band polypeptide was detected by immunoblot in all red cell samples but D−−, using a rabbit anti‐Rh polypeptide antibody (MPC8) raised against the C‐terminal domain of Rh proteins. This 21 kD polypeptide most probably results from the translation of an alternatively spliced RHCE gene transcript.This study demonstrates that LOR‐15C9 detects an epitope on the RhD protein that is independent of the membrane environment, and therefore could be a useful tool for the study of RhD polypeptides.
Title: A human monoclonal anti‐D antibody which detects a nonconformation‐dependent epitope on the RhD protein by immunoblot
Description:
We describe the first human monoclonal anti‐D (LOR‐15C9) which reacts with a D‐specific motif exposed either on a native form on intact D‐positive red cells or on a denatured form of the RhD protein (33 kD), and detected by immunoblotting.
LOR‐15C9 was able to precipitate RhD but not RhcE proteins produced by in vitro transcription‐translation assays.
The reactivity of the antibody, using panels of red cells with various partial D phenotypes known to lack some D epitopes and corresponding in RHD gene variants, suggested that LOR‐15C9 reactivity depends on the portion of the RhD polypeptide encoded by the exon 7 (amino acids 314–358).
These findings correlate well with the reactivity of LOR‐15C9 with erythrocytes of some nonhuman primates (Dgor‐positive gorillas), but not of chimpanzee and Old or New World monkeys.
In membrane proteins from partial DVI red cells, LOR‐15C9 detected two proteins of molecular weight 33 and 21 kD; the presence of the latter was specific for category DVI and presumably represented the product of an alternatively spliced RHDVI transcript in these cells.
This is consistent with the finding that LOR‐15C9 can precipitate a shortened D protein mutant resulting from in vitro transcription‐translation and lacking amino‐acids 163–313 encoded by exons 4–6.
In addition, a 21 kD band polypeptide was detected by immunoblot in all red cell samples but D−−, using a rabbit anti‐Rh polypeptide antibody (MPC8) raised against the C‐terminal domain of Rh proteins.
This 21 kD polypeptide most probably results from the translation of an alternatively spliced RHCE gene transcript.
This study demonstrates that LOR‐15C9 detects an epitope on the RhD protein that is independent of the membrane environment, and therefore could be a useful tool for the study of RhD polypeptides.
Related Results
RHD Genotyping of Blood Donors May Avoid Anti-D Immunization.
RHD Genotyping of Blood Donors May Avoid Anti-D Immunization.
Abstract
Antigen D compatible transfusion is standard practice in modern transfusion therapy, warranting proper antigen D typing in all blood donors. Blood group gen...
Period Prevalence of Rheumatic Heart Disease and the Need for a Centralized Patient Registry in American Samoa, 2016 to 2018
Period Prevalence of Rheumatic Heart Disease and the Need for a Centralized Patient Registry in American Samoa, 2016 to 2018
Background
Rheumatic heart disease (RHD) is a severe, chronic complication of acute rheumatic fever, triggered by group A streptococcal pharyngitis. Centralized patient...
A snowball approach for screening of asymptomatic Rheumatic Heart Disease among school age children in Ethiopia: A comparative cross-sectional study
A snowball approach for screening of asymptomatic Rheumatic Heart Disease among school age children in Ethiopia: A comparative cross-sectional study
Abstract
Background
Rheumatic heart disease (RHD) is a common complication of acute rheumatic fever (ARF). ARF and RHD are the ...
Prevalence of rheumatic heart disease in North‐Central Nigeria: a school‐based cross‐sectional pilot study
Prevalence of rheumatic heart disease in North‐Central Nigeria: a school‐based cross‐sectional pilot study
AbstractObjectivesTo present epidemiological data on rheumatic heart disease (RHD), the most common acquired heart disease in children and young adults in low‐ and middle‐income co...
RhD negative women transfused RhD positive blood: Alloimmunization prophylaxis protocol and experiences
RhD negative women transfused RhD positive blood: Alloimmunization prophylaxis protocol and experiences
Abstract
Introduction/Objective
Preventing allomiunization from D-mismatched transfusions, i.e., transfusion RhD positive (RhD+)...
Establishing a Rheumatic Heart Disease Registry in Ethiopia Based on the ARGI
Establishing a Rheumatic Heart Disease Registry in Ethiopia Based on the ARGI
Ethiopia faces a significant burden of RHD, which leads to substantial morbidity and mortality, particularly among children and young adults. However, comprehensive, region-specifi...
The TEMPI syndrome: Unique patient specific monoclonal antibodies as tools for target antigen discovery
The TEMPI syndrome: Unique patient specific monoclonal antibodies as tools for target antigen discovery
Abstract
BACKGROUND. In 2011, we discovered the TEMPI syndrome. TEMPI is a rare monoclonal gammopathy of clinical signif...
Simplified echocardiographic screening criteria for rheumatic heart disease
Simplified echocardiographic screening criteria for rheumatic heart disease
Abstract
Introduction
Rheumatic Heart Disease (RHD) remains a major health problem in many low and middle-income countries. The ...

